|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Nov―08 |
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study |
David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, et al. (+35) Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, Raed Alroughani, Cavit Boz, Murat Terzi, Tomas Kalincik, Yolanda Blanco, Matteo Foschi, Andrea Surcinelli, Katherine Buzzard, Olga Skibina, Guy Laureys, Liesbeth Van Hijfte, Cristina Ramo-Tello, Aysun Soysal, Jose Luis Sanchez-Menoyo, Mario Habek, Elisabetta Cartechini, Juan Ignacio Rojas, Rana Karabudak, Barbara Willekens, Talal Al-Harbi, Yara Fragoso, Tamara Castillo-Triviño, Danny Decoo, Maria Cecilia Aragon de Vecino, Eli Skromne, Carmen-Adella Sirbu, Chao Zhu, Daniel Merlo, Melissa Gresle, Helmut Butzkueven, Anneke Van Der Walt |
2 |
[GO] |
2024―Mai―31 |
Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19 |
Matthias Kohl |
3 |
[GO] |
2024―Mai―31 |
Author response to Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19 |
Michael Fleischer, Fabian Szepanowski, Anne K. Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, et al. (+3) Mark Stettner, Lothar Volbracht, Christoph Kleinschnitz |
4 |
[GO] |
2024―Feb―12 |
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19 |
Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, et al. (+3) Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz |
5 |
[GO] |
2022―Dez―09 |
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination |
Simon Faissner, Neele Heitmann, Ricarda Rohling, Ulas Ceylan, Marielena Bongert, Carlos Plaza-Sirvent, et al. (+7) Corinna Marheinecke, Xiomara Pedreiturria, Ilya Ayzenberg, Kerstin Hellwig, Ingo Schmitz, Stephanie Pfaender, Ralf Gold |
6 |
[GO] |
2022―Nov―08 |
Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC) |
Tjalf Ziemssen, Marie Groth, Benedict Rauser, Tobias Bopp |
7 |
[GO] |
2022―Okt―10 |
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System |
Maximilian Pistor, Robert Hoepner, Andreas G.F. Hoepner, Yanan Lin, Simon Jung, Claudio L. Bassetti, et al. (+2) Andrew Chan, Anke Salmen |
8 |
[GO] |
2022―Jul―23 |
Mid-term MRI evaluation reveals microstructural white matter alterations in COVID-19 fully recovered subjects with anosmia presentation |
Laura Pelizzari, Marta Cazzoli, Susanna Lipari, Maria Marcella Laganà, Monia Cabinio, Sara Isernia, et al. (+3) Alice Pirastru, Mario Clerici, Francesca Baglio |
9 |
[GO] |
2022―Jun―25 |
Comment on ‘MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report’ |
Josef Finsterer, Fulvio A Scorza |
10 |
[GO] |
2022―Mai―25 |
Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients |
Paraskevi C. Fragkou, Lina Palaiodimou, Maria Ioanna Stefanou, Aristeidis H. Katsanos, Vaia Lambadiari, Dimitrios Paraskevis, et al. (+9) Elisabeth Andreadou, Dimitra Dimopoulou, Christina Zompola, Panagiotis Ferentinos, Theodoros I. Vassilakopoulos, Anastasia Kotanidou, Petros P. Sfikakis, Sotirios Tsiodras, Georgios Tsivgoulis |
11 |
[GO] |
2022―Mai―18 |
Corrigendum to Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
|
12 |
[GO] |
2022―Apr―23 |
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study |
Tobias Moser, Ciara O’Sullivan, Ferdinand Otto, Wolfgang Hitzl, Georg Pilz, Kerstin Schwenker, et al. (+5) Cornelia Mrazek, Elisabeth Haschke-Becher, Eugen Trinka, Peter Wipfler, Andrea Harrer |
13 |
[GO] |
2022―Mrz―12 |
Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response |
Cédric Hirzel, Denis Grandgirard, Bernard Surial, Manon F. Wider, David Leppert, Jens Kuhle, et al. (+6) Laura N. Walti, Joerg C. Schefold, Thibaud Spinetti, Franziska Suter-Riniker, Ronald Dijkman, Stephen L. Leib |
14 |
[GO] |
2022―Jan―19 |
MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report |
Jordi Kühne Escolà, Cornelius Deuschl, Andreas Junker, Fabian Dusse, Refik Pul, Christoph Kleinschnitz, et al. (+2) Martin Köhrmann, Benedikt Frank |
15 |
[GO] |
2021―Dez―08 |
Anti-GFAP-antibody positive postinfectious acute cerebellar ataxia and myoclonus after COVID-19: a case report |
Livia Asan, Stephan Klebe, Christoph Kleinschnitz, Mark Stettner, Martin Köhrmann |
16 |
[GO] |
2021―Dez―07 |
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, et al. (+5) Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
17 |
[GO] |
2021―Aug―14 |
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab |
Rocco Capuano, Giovanna Donnarumma, Alvino Bisecco, Elena Grimaldi, Miriana Conte, Alessandro d’Ambrosio, et al. (+9) Federica Matrone, Mario Risi, Riccardo Maria Borgo, Manuela Altieri, Federica Giuliano, Nicola Coppola, Massimiliano Galdiero, Gioacchino Tedeschi, Antonio Gallo |
18 |
[GO] |
2021―Jul―23 |
Oropharyngeal swab for SARS-CoV-2 test causing atypical internal carotid artery dissection and stroke in a patient after mild COVID-19 |
Livia Asan, Cornelius Deuschl, Michael Forsting, Christoph Kleinschnitz, Martin Köhrmann |
19 |
[GO] |
2021―Jul―07 |
Persistent decline of hospitalizations for acute stroke and acute coronary syndrome during the second wave of the COVID-19 pandemic in Greece: collateral damage unaffected |
Christos Katsouras, Georgios Tsivgoulis, Michail Papafaklis, Theodore Karapanayiotides, Dimitrios Alexopoulos, Evangelos Ntais, et al. (+13) Georgia Papagiannopoulou, Ioanna Koutroulou, Antonios Ziakas, Georgios Sianos, Antonios Kouparanis, Paraskevi Trivilou, Christos Ballas, Ioanna Samara, Maria Kosmidou, Lina Palaiodimou, Nikolaos Grigoriadis, Lampros K. Michalis, Sotirios Giannopoulos |
20 |
[GO] |
2021―Jul―07 |
The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany |
Daniel Richter, Simon Faissner, Dirk Bartig, Lars Tönges, Kerstin Hellwig, Ilya Ayzenberg, et al. (+2) Christos Krogias, Ralf Gold |
21 |
[GO] |
2021―Jun―04 |
Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Hela-Felicitas Petereit, Hayrettin Tumani, Uwe K. Zettl |
22 |
[GO] |
2021―Jun―04 |
IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments |
Jürgen Wienands |
23 |
[GO] |
2021―Jun―03 |
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, et al. (+5) Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich |
24 |
[GO] |
2021―Mai―31 |
Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Amanda L. Piquet, John R. Corboy, Timothy L. Vollmer |
25 |
[GO] |
2021―Mai―18 |
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies |
Christoph Friedli, Lara Diem, Helly Hammer, Nicole Kamber, Franziska Suter-Riniker, Stephen Leib, et al. (+4) Andrew Chan, Cédric Hirzel, Robert Hoepner, Anke Salmen |
26 |
[GO] |
2021―Apr―23 |
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies |
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, et al. (+5) Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich |
27 |
[GO] |
2021―Feb―27 |
Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection |
Michael Fleischer, Martin Köhrmann, Sebastian Dolff, Fabian Szepanowski, Karsten Schmidt, Frank Herbstreit, et al. (+16) Cansu Güngör, Benjamin Stolte, Katharina Marie Steiner, Christine Stadtler, Joachim Riße, Melanie Fiedler, Gerd Meyer zu Hörste, Anne-K. Mausberg, Clemens Kill, Michael Forsting, Ulrich Sure, Ulf Dittmer, Oliver Witzke, Thorsten Brenner, Christoph Kleinschnitz, Mark Stettner |
28 |
[GO] |
2021―Feb―05 |
Extensive cerebellar involvement and cognitive impairment in COVID-19-associated acute necrotizing encephalopathy |
Dumitru Ciolac, Igor Crivorucica, Eremei Zota, Nadejda Gorincioi, Daniela Efremova, Diana Manea, et al. (+3) Veaceslav Crivorucica, Mihail Ciocanu, Stanislav A. Groppa |
29 |
[GO] |
2020―Dez―10 |
COVID-19 and cerebrovascular diseases: a comprehensive overview |
Georgios Tsivgoulis, Lina Palaiodimou, Ramin Zand, Vasileios Arsenios Lioutas, Christos Krogias, Aristeidis H. Katsanos, et al. (+10) Ashkan Shoamanesh, Vijay K. Sharma, Shima Shahjouei, Claudio Baracchini, Charalambos Vlachopoulos, Rossetos Gournellis, Petros P. Sfikakis, Else Charlotte Sandset, Andrei V. Alexandrov, Sotirios Tsiodras |
30 |
[GO] |
2020―Jun―09 |
Neurological manifestations and implications of COVID-19 pandemic |
Georgios Tsivgoulis, Lina Palaiodimou, Aristeidis H. Katsanos, Valeria Caso, Martin Köhrmann, Carlos Molina, et al. (+12) Charlotte Cordonnier, Urs Fischer, Peter Kelly, Vijay K. Sharma, Amanda C. Chan, Ramin Zand, Amrou Sarraj, Peter D. Schellinger, Konstantinos I. Voumvourakis, Nikolaos Grigoriadis, Andrei V. Alexandrov, Sotirios Tsiodras |
31 |
[GO] |
2020―Mrz―28 |
Potential neurological symptoms of COVID-19 |
Hai-Yang Wang, Xue-Lin Li, Zhong-Rui Yan, Xiao-Pei Sun, Jie Han, Bing-Wei Zhang |
|